Analysts’ Viewpoint
Manufacturers in the global bioprocess technology market are capitalizing on government stimulus packages to stay financially afloat amid ongoing COVID-19 pandemic. Untapped opportunities for the treatment of chronic diseases at genetic level are helping to bridge the gap between individuals who are keen on accessing treatment alternatives. Hence, companies in the bioprocess technology market should invest in R&D to innovate in cell-level and DNA-level treatment options to increase life expectancy of patients. Although disposable systems are usually preferred in early stage development, stainless steel bioreactors are still being extensively utilized for full-scale production in North America. On the other hand, the market in Europe is being steered by the rise in demand for different products such as monoclonal antibodies, antibiotics, and biosimilars.
The high prevalence of cancer and other chronic diseases is fueling the demand for innovations in the bioprocess technology. The ever-expanding pharmaceutical industry is translating into revenue opportunities for stakeholders in the global bioprocess technology market. The surge in the demand for vaccines and proteins has induced pharmaceutical and biotechnology companies to increase production of therapeutics, bolster research studies, and other investigations.
Biopharmaceutical outsourcing is emerging as a promising strategy to address the unmet medical needs among patients. This has led to rise in usage of bioprocessing systems with better process efficiency and throughput. These systems offer an advantage for adherence with regulatory compliance processes. An increasing number of biopharmaceutical companies are opting for single-use systems, as they deliver cost-efficiency and technological advancements due to growing capacities and capabilities.
Manufacturers in the bioprocess technology market have been working at break-neck speeds amid the ongoing COVID-19 pandemic to ensure robust supply of consumables, instruments, cell counters, and the likes. As the U.S. and other regions of the world with high population such as India and Brazil are bracing themselves, Shanghai in China is yet again under great emphasis for the Wuhan virus.
Even as the production and movement of goods are slow, manufacturers are rethinking their budget for allocating sufficient capital & expenses to ensure business continuity. They are increasing the availability of life-saving medical devices to improve patient outcomes.
The bioprocess technology market is estimated to grow at a robust CAGR throughout the assessment period. However, this market is governed by stringent regulatory framework, since public health concerns are a top priority for CMOs (contract manufacturing organizations), CROs (contract research organizations), and CDMOs (contract development and manufacturing organizations).
Hence, stakeholders should increase R&D to expand their creation limits and reduce the turnaround time to introduce new medications in the market. Companies should invest in bioprocess hardware to offer imaginative, safe, and highly precise solutions to fulfill the expansion in need from biopharmaceutical organizations.
The lack of research for life-threatening health conditions such as the Crohn’s disease is creating opportunity windows for companies in the bioprocess technology market. Healthcare solutions at cell-level hold promising potentials to treat diseases at the foundation level. Cell-level treatment innovations have the capability to detect early symptoms of chronic diseases and can help to reduce its severity in future, thus benefitting patient quality of life. These strategies have the potential to increase life-expectancy, especially in the geriatric population. Thus, treatments that can alter the DNA at genetic level have the capability to improve patient outcomes.
Constant innovations in the bioprocess technology market is leading to market expansion. Bioprocess technology finds application in end-use ventures for the assembling of biomaterials such as catalysts, anti-microbial medications, food & farming items, antibodies, and drug supplements. Moreover, this technology tracks down the application for the creation of biodegradable & climate agreeable chemicals, development of elective items to treat diseases, and facilitate the creation & assessment of more secure food materials.
As procedures and instrumentation become additionally modern, bioprocesses may find applications in different areas where substance processes are presently utilized. Biological, engineering, and mathematical processes are being pooled to achieve bioprocessing activities such as media production, biocatalysts, and the designing of bioreactor substrates. Companies in the bioprocess technology market are gaining cognizance about the benefits of the single-use bioprocessing technologies and are diversifying into the adoption for hybrid systems in their facilities.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 22.4 Bn |
|
Market Forecast Value in 2031 |
US$ 53.7 Bn |
|
Growth Rate (CAGR) |
8.3% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Bioprocess Technology Market – Segmentation
TMR’s study on the global bioprocess technology market includes information divided into four segments: product, application, end-user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global bioprocess technology market are discussed in detail.
| Product |
|
| Application |
|
| End-user |
|
| Region |
|
Bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031
Bioprocess technology market is estimated to expand at a CAGR of 8.3% from 2021 to 2031
Bioprocess technology market is driven by rise in number of CMOs that have small flexible facilities and are beginning to rely on single-use equipment in their operations
North America accounted for a major share of the global bioprocess technology market
Key players operating in the global bioprocess technology market include Thermo Fisher Scientific, Inc., Siemens Healthineers, GE Healthcare (General Electric Company), Sartorius AG, Becton
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Bioprocess Technology Market Forecast
4.4. Global Bioprocess Technology Market Outlook
5. Market Outlook
5.1. Technological Advancement
5.2. List of Distributors
5.3. Type of Analyzers Used/Preferred in the Market
5.4. Major Assays Performed by Customers
5.5. Pricing Analysis
5.6. Key Brand Analysis
5.7. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Bioprocess Technology Market Analysis and Forecast, by Product Type
6.1. Introduction
6.2. Global Bioprocess Technology Market Value Share Analysis, by Product Type
6.3. Global Bioprocess Technology Market Forecast, by Product Type
6.3.1. Consumables and Accessories
6.3.1.1. Culture Media
6.3.1.2. Reagents
6.3.1.3. Others
6.3.2. Instruments
6.3.2.1. Bioprocess Analyzers
6.3.2.2. Blood Gas Analyzers
6.3.2.3. Osmometers
6.3.2.4. Cell Counter
6.3.2.5. Incubators
6.3.2.6. Bioreactors
6.3.2.7. Others (centrifugation, spectrometer, filtration)
6.4. Global Bioprocess Technology Market Analysis, by Product Type
6.5. Global Bioprocess Technology Market Attractiveness Analysis, by Product Type
7. Global Bioprocess Technology Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Global Bioprocess Technology Market Value Share Analysis, by Application
7.3. Global Bioprocess Technology Market Forecast, by Application
7.3.1. Antibiotics
7.3.2. Recombinant Proteins
7.3.3. Monoclonal Antibodies
7.3.4. Biosimilars
7.4. Global Bioprocess Technology Market Analysis, by Application
7.5. Global Bioprocess Technology Market Attractiveness Analysis, by Application
8. Global Bioprocess Technology Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Global Bioprocess Technology Market Value Share Analysis, by End-user
8.3. Global Bioprocess Technology Market Forecast, by End-user
8.3.1. Biopharmaceutical Companies
8.3.2. Contract Manufacturing Organizations
8.3.3. Contract Research Organizations
8.3.4. Food & Feed Industry
8.3.5. Academic & Research Organizations
8.4. Global Bioprocess Technology Market Analysis, by End-user
8.5. Global Bioprocess Technology Market Attractiveness Analysis, by End-user
9. Global Bioprocess Technology Market Analysis and Forecast, by Region
9.1. Global Bioprocess Technology Market Analysis, by Region
9.2. Global Bioprocess Technology Market Value Share and Attractiveness Analysis, by Region
9.3. Global Bioprocess Technology Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Bioprocess Technology Market Analysis
10.1. North America Bioprocess Technology Market Overview
10.2. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country
10.3. North America Bioprocess Technology Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type
10.5. North America Bioprocess Technology Market Forecast, by Product Type
10.5.1. Consumables and Accessories
10.5.1.1. Culture Media
10.5.1.2. Reagents
10.5.1.3. Others
10.5.2. Instruments
10.5.2.1. Bioprocess Analyzers
10.5.2.2. Blood Gas Analyzers
10.5.2.3. Osmometers
10.5.2.4. Cell Counter
10.5.2.5. Incubators
10.5.2.6. Bioreactors
10.5.2.7. Others (centrifugation, spectrometer, filtration)
10.6. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application
10.7. North America Bioprocess Technology Market Forecast, by Application
10.7.1. Antibiotics
10.7.2. Recombinant Proteins
10.7.3. Monoclonal Antibodies
10.7.4. Biosimilars
10.8. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Bioprocess Technology Market Forecast, by End-user
10.9.1. Biopharmaceutical Companies
10.9.2. Contract Manufacturing Organizations
10.9.3. Contract Research Organizations
10.9.4. Food & Feed Industry
10.9.5. Academic & Research Organizations
11. Europe Bioprocess Technology Market Analysis
11.1. Europe Bioprocess Technology Market Overview
11.2. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country
11.3. Europe Bioprocess Technology Market Forecast, by Country
11.3.1. U.K.
11.3.2. France
11.3.3. Italy
11.3.4. Germany
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type
11.5. Europe Bioprocess Technology Market Forecast, by Product Type
11.5.1. Consumables and Accessories
11.5.1.1. Culture Media
11.5.1.2. Reagents
11.5.1.3. Others
11.5.2. Instruments
11.5.2.1. Bioprocess Analyzers
11.5.2.2. Blood Gas Analyzers
11.5.2.3. Osmometers
11.5.2.4. Cell Counter
11.5.2.5. Incubators
11.5.2.6. Bioreactors
11.5.2.7. Others (Centrifugation, Spectrometer, Filtration)
11.6. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application
11.7. Europe Bioprocess Technology Market Forecast, by Application
11.7.1. Antibiotics
11.7.2. Recombinant Proteins
11.7.3. Monoclonal Antibodies
11.7.4. Biosimilars
11.8. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Bioprocess Technology Market Forecast, by End-user
11.9.1. Biopharmaceutical Companies
11.9.2. Contract Manufacturing Organizations
11.9.3. Contract Research Organizations
11.9.4. Food & Feed Industry
11.9.5. Academic & Research Organizations
12. Asia Pacific Bioprocess Technology Market Analysis
12.1. Asia Pacific Bioprocess Technology Market Overview
12.2. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country
12.3. Asia Pacific Bioprocess Technology Market Forecast, by Country
12.3.1. China
12.3.2. Japan
12.3.3. India
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type
12.5. Asia Pacific Bioprocess Technology Market Forecast, by Product Type
12.5.1. Consumables and Accessories
12.5.1.1. Culture Media
12.5.1.2. Reagents
12.5.1.3. Others
12.5.2. Instruments
12.5.2.1. Bioprocess Analyzers
12.5.2.2. Blood Gas Analyzers
12.5.2.3. Osmometers
12.5.2.4. Cell Counter
12.5.2.5. Incubators
12.5.2.6. Bioreactors
12.5.2.7. Others (Centrifugation, Spectrometer, Filtration)
12.6. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application
12.7. Asia Pacific Bioprocess Technology Market Forecast, by Application
12.7.1. Antibiotics
12.7.2. Recombinant Proteins
12.7.3. Monoclonal Antibodies
12.7.4. Biosimilars
12.8. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Bioprocess Technology Market Forecast, by End-user
12.9.1. Biopharmaceutical Companies
12.9.2. Contract Manufacturing Organizations
12.9.3. Contract Research Organizations
12.9.4. Food & Feed Industry
12.9.5. Academic & Research Organizations
13. Latin America Bioprocess Technology Market Analysis
13.1. Latin America Bioprocess Technology Market Overview
13.2. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country
13.3. Latin America Bioprocess Technology Market Forecast, by Country
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type
13.5. Latin America Bioprocess Technology Market Forecast, by Product Type
13.5.1. Consumables and Accessories
13.5.1.1. Culture Media
13.5.1.2. Reagents
13.5.1.3. Others
13.5.2. Instruments
13.5.2.1. Bioprocess Analyzers
13.5.2.2. Blood Gas Analyzers
13.5.2.3. Osmometers
13.5.2.4. Cell Counter
13.5.2.5. Incubators
13.5.2.6. Bioreactors
13.5.2.7. Others (centrifugation, spectrometer, filtration)
13.6. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application
13.7. Latin America Bioprocess Technology Market Forecast, by Application
13.7.1. Antibiotics
13.7.2. Recombinant Proteins
13.7.3. Monoclonal Antibodies
13.7.4. Biosimilars
13.8. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Bioprocess Technology Market Forecast, by End-user
13.9.1. Biopharmaceutical Companies
13.9.2. Contract Manufacturing Organizations
13.9.3. Contract Research Organizations
13.9.4. Food & Feed Industry
13.9.5. Academic & Research Organizations
14. Middle East & Africa Bioprocess Technology Market Analysis
14.1. Middle East & Africa Bioprocess Technology Market Overview
14.2. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country
14.3. Middle East & Africa Bioprocess Technology Market Forecast, by Country
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type
14.5. Middle East & Africa Bioprocess Technology Market Forecast, by Product Type
14.5.1. Consumables and Accessories
14.5.1.1. Culture Media
14.5.1.2. Reagents
14.5.1.3. Others
14.5.2. Instruments
14.5.2.1. Bioprocess Analyzers
14.5.2.2. Blood Gas Analyzers
14.5.2.3. Osmometers
14.5.2.4. Cell Counter
14.5.2.5. Incubators
14.5.2.6. Bioreactors
14.5.2.7. Others (centrifugation, spectrometer, filtration)
14.6. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application
14.7. Middle East & Africa Bioprocess Technology Market Forecast, by Application
14.7.1. Antibiotics
14.7.2. Recombinant Proteins
14.7.3. Monoclonal Antibodies
14.8. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Bioprocess Technology Market Forecast, by End-user
14.9.1. Biopharmaceutical Companies
14.9.2. Contract Manufacturing Organizations
14.9.3. Contract Research Organizations
14.9.4. Food & Feed Industry
14.9.5. Academic & Research Organizations
15. Company Profiles
15.1. Thermo Fisher Scientific, Inc.
15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.2. Product Portfolio
15.1.3. Financial Overview
15.1.4. SWOT Analysis
15.1.5. Strategic Overview
15.2. Siemens Healthineers
15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2. Product Portfolio
15.2.3. Financial Overview
15.2.4. SWOT Analysis
15.2.5. Strategic Overview
15.3. GE Healthcare (General Electric Company)
15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2. Product Portfolio
15.3.3. Financial Overview
15.3.4. SWOT Analysis
15.3.5. Strategic Overview
15.4. Sartorius AG
15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2. Product Portfolio
15.4.3. SWOT Analysis
15.4.4. Strategic Overview
15.5. Becton, Dickinson and Company
15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2. Product Portfolio
15.5.3. SWOT Analysis
15.5.4. Strategic Overview
15.6. Danaher Corporation
15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.6.2. Product Portfolio
15.6.3. Financial Overview
15.6.4. SWOT Analysis
15.6.5. Strategic Overview
15.7. Eppendorf AG
15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.7.2. Product Portfolio
15.7.3. Financial Overview
15.7.4. SWOT Analysis
15.7.5. Strategic Overview
15.8. Lonza
15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.8.2. Product Portfolio
15.8.3. Financial Overview
15.8.4. SWOT Analysis
15.8.5. Strategic Overview
15.9. Advanced Instruments
15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.9.2. Product Portfolio
15.9.3. SWOT Analysis
15.9.4. Strategic Overview
15.10. Nova Biomedical
15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.10.2. Product Portfolio
15.10.3. SWOT Analysis
15.10.4. Strategic Overview
15.11. F. Hoffmann-La Roche Ltd
15.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.11.2. Product Portfolio
15.11.3. Financial Overview
15.11.4. SWOT Analysis
15.11.5. Strategic Overview
List of Tables
Table 01: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031
Table 08: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 09: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031
Table 14: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 15: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031
Table 20: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 21: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 22: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 23: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 25: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031
Table 26: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 27: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 29: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 30: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 31: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031
Table 32: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031
Table 33: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 34: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Bioprocess Technology Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Bioprocess Technology Market Value Share, by Product Type (2020)
Figure 03: Global Bioprocess Technology Market Value Share, by End-user (2020)
Figure 04: Global Bioprocess Technology Market Value Share, by Application (2020)
Figure 05: Global Bioprocess Technology Market Value Share, by Region (2020)
Figure 06: Global Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 07: Global Bioprocess Technology Market Revenue (US$ Mn), by Consumables & Accessories, 2017–2031
Figure 08: Global Bioprocess Technology Market Revenue (US$ Mn), by Instruments, 2017–2031
Figure 09: Global Bioprocess Technology Market Revenue (US$ Mn), by Culture Media, 2017–2031
Figure 10: Global Bioprocess Technology Market Revenue (US$ Mn), by Reagents, 2017–2031
Figure 11: Global Bioprocess Technology Market Revenue (US$ Mn), by Others, 2017–2031
Figure 12: Global Bioprocess Technology Market Revenue (US$ Mn), by Bioprocess Analyzers, 2017–2031
Figure 13: Global Bioprocess Technology Market Revenue (US$ Mn), by Blood Gas Analyzers, 2017–2031
Figure 14: Global Bioprocess Technology Market Revenue (US$ Mn), by Osmometers, 2017–2031
Figure 15: Global Bioprocess Technology Market Revenue (US$ Mn), by Cell Counter, 2017–2031
Figure 16: Global Bioprocess Technology Market Revenue (US$ Mn), by Incubators, 2017–2031
Figure 17: Global Bioprocess Technology Market Revenue (US$ Mn), by Bioreactors, 2017–2031
Figure 18: Global Bioprocess Technology Market Revenue (US$ Mn), by Others, 2017–2031
Figure 19: Global Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 20: Global Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031
Figure 21: Global Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031
Figure 22: Global Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031
Figure 23: Global Bioprocess Technology Market Revenue (US$ Mn), by Antibiotics, 2017–2031
Figure 24: Global Bioprocess Technology Market Revenue (US$ Mn), by Recombinant Proteins, 2017–2031
Figure 25: Global Bioprocess Technology Market Revenue (US$ Mn), by Monoclonal Antibodies, 2017–2031
Figure 26: Global Bioprocess Technology Market Revenue (US$ Mn), by Biosimilars, 2017–2031
Figure 27: Global Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031
Figure 28: Global Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031
Figure 29: Global Bioprocess Technology Market Revenue (US$ Mn), by Biopharmaceutical Companies, 2017–2031
Figure 30: Global Bioprocess Technology Market Revenue (US$ Mn), by Contract Manufacturing 32s, 2017–2031
Figure 31: Global Bioprocess Technology Market Revenue (US$ Mn), by Contract Research Organizations, 2017–2031
Figure 32: Global Bioprocess Technology Market Revenue (US$ Mn), by Food & Feed Industry, 2017–2031
Figure 33: Global Bioprocess Technology Market Revenue (US$ Mn), by Academic & Research Organizations, 2017–2031
Figure 34: Global Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 35: Global Bioprocess Technology Market Value Share Analysis, by Region, 2020 and 2031
Figure 36: Global Bioprocess Technology Market Attractiveness Analysis, by Region, 2021-2031
Figure 37: North America Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 38: North America Bioprocess Technology Market Value Share (%), by Country, 2020 and 2031
Figure 39: North America Bioprocess Technology Market Attractiveness Analysis, by Country, 2021–2031
Figure 40: North America Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 41: North America Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 42: North America Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031
Figure 43: North America Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031
Figure 44: North America Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031
Figure 45: North America Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031
Figure 46: North America Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031
Figure 47: North America Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031
Figure 48: North America Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031
Figure 49: North America Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 50: Europe Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Europe Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 52: Europe Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 53: Europe Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 54: Europe Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 55: Europe Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031
Figure 56: Europe Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031
Figure 57: Europe Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031
Figure 58: Europe Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031
Figure 59: Europe Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031
Figure 60: Europe Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031
Figure 61: Europe Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031
Figure 62: Europe Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 63: Asia Pacific Bioprocess Technology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 64: Asia Pacific Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 65: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 66: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 67: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 68: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031
Figure 69: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031
Figure 70: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031
Figure 71: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031
Figure 72: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031
Figure 73: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031
Figure 74: Asia Pacific Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031
Figure 75: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 76: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 77: Latin America Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 78: Latin America Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 79: Latin America Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 80: Latin America Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 81: Latin America Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031
Figure 82: Latin America Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031
Figure 83: Latin America Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031
Figure 84: Latin America Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031
Figure 85: Latin America Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031
Figure 86: Latin America Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031
Figure 87: Latin America Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031
Figure 88: Latin America Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031
Figure 89: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 90: Middle East & Africa Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 91: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 92: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 93: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 94: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031
Figure 95: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031
Figure 96: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031
Figure 97: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031
Figure 98: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031
Figure 99: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031
Figure 100: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031
Figure 101: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bioprocess Technology Market
